<DOC>
	<DOCNO>NCT00476723</DOCNO>
	<brief_summary>The trial randomise HIV/HBV co-infected individual different HBV-active antiretroviral therapy treatment regimen .</brief_summary>
	<brief_title>HBV-specific T-cell Immunity Individuals With HIV/HBV Co-infection</brief_title>
	<detailed_description>Longitudinal study circulate intra-hepatic HBV-specific T-cell immunity set randomise , control , international , multi-centre outpatient trial . The trial randomise HIV/HBV co-infected individual different HBV-active antiretroviral therapy treatment regimen . Study population : Patients HIV/HBV co-infection naive HIV/HBV therapy , detectable HBV viremia willing start antiretroviral therapy .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Coinfection</mesh_term>
	<criteria>HIV positive hepatitisB coinfected HBV/HIV therapy naive &gt; 18 year age Unable sign consent form .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>Hepatitis coinfection</keyword>
</DOC>